Full-Time

Senior Lab Operations Specialist

Posted on 9/10/2024

Editas Medicine

Editas Medicine

201-500 employees

Develops gene editing treatments using CRISPR

Biotechnology

Mid, Senior

Cambridge, MA, USA

Category
Lab & Research
Life Sciences
Medical Research
Required Skills
Management
PowerPoint/Keynote/Slides
Requirements
  • Bachelors in a science or related field with 3+ years of biotech experience
  • Strong background in asset management using Computerized Maintenance Management System (CMMS) and Environmental Continuous Monitoring System (CMS)
  • Knowledge of lab equipment maintenance (ex: freezer, fridges, centrifuges, liquid handlers, BSC, etc.)
  • Familiarity with the regulations and interactions with various state and federal agencies including EPA, OSHA, DOT, MA DEP, MA DPH, and others
  • Knowledge of basic computer systems (ex: Microsoft Outlook, Microsoft Office, PowerPoint), ERP systems and other tools required for purchasing and equipment asset management
Responsibilities
  • The daily operations of the laboratory, providing essential support to our research team by partnering with them to optimize processes, increase efficiency, and anticipate and solve problems.
  • Anticipate, troubleshoot, and resolve problems associated with work within the laboratory setting, including off-hours responses to laboratory emergencies.
  • Manage shipping for domestic and international shipments of lab materials, including the preparation of material for shipment and receiving from external vendors.
  • Serve as the primary point of contact with vendors and laboratory service providers.
  • Establish lab procedures; create and manage lab-related documentation, and organizational processes such as annual laboratory cleanouts, de-frosting of freezers, micropipette calibrations, freezer/refrigerator inventory, and consumables inventory.
  • Maintain cryogenics and compressed gases, including but not limited to placing requests with external vendor, monitoring, and swapping out cylinders and dewars, as needed.
  • Collaborate regularly with scientists to identify and address any workflow bottlenecks, inefficiencies, opportunities for process improvement, and logistical or administrative issues in the lab.
  • Support lab safety and regulatory compliance, including tracking of biologics, chemicals, and hazardous materials, and enforcing PPE Policy and lab safety rules.
  • Handle and track biological waste and hazardous waste.
  • Manage laboratory space to maximize effective square footage, factoring equipment utilization, workflow, and assigned bench allocations.
  • Collaborate with internal partners including Facilities, Legal, Procurement, IT, etc.
  • Responsible for leading and coordinating laboratory expansions and relocations, laboratory design and redesign, and space management.
  • Ensure a safe working environment by identifying, reporting, and eliminating potential workplace hazards
  • In partnership with EHS, perform routine lab safety inspections and walkthroughs, and participate in monthly safety committee meetings.

Editas Medicine focuses on gene editing using CRISPR technology, which allows for precise modifications to DNA in cells. This technique has the potential to correct genetic defects that lead to various diseases. The company is engaged in the entire process of drug development, from discovering new treatments to manufacturing and selling them. Editas Medicine aims to create effective and lasting therapies that can enhance the quality of life for patients suffering from serious health conditions. Unlike many competitors, Editas has a diverse pipeline of experimental medicines and actively shares clinical data to keep stakeholders informed. The ultimate goal is to provide transformative treatments for patients worldwide.

Company Stage

IPO

Total Funding

$321M

Headquarters

Cambridge, Massachusetts

Founded

2013

Growth & Insights
Headcount

6 month growth

2%

1 year growth

22%

2 year growth

15%
Simplify Jobs

Simplify's Take

What believers are saying

  • Collaboration with Genevant Sciences could enhance targeted delivery systems for gene therapies.
  • $50 million financing with DRI Healthcare Trust supports pipeline advancement.
  • Promising EDIT-101 trial results highlight potential in treating genetic blindness.

What critics are saying

  • 65% workforce reduction may lead to operational challenges and delays.
  • Pivot to in-vivo gene editing could increase R&D costs and delay market entry.
  • Failure to secure sickle cell partner may limit advancement in this area.

What makes Editas Medicine unique

  • Editas Medicine leverages CRISPR technology for precise gene editing therapeutics.
  • The company focuses on in-vivo gene editing, targeting stem cells and the liver.
  • Editas has a strong intellectual property portfolio in genome editing technologies.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE